Normalization of serum cortisol concentration with opioid treatment of severe chronic pain

Pain Medicine

Volumn 3, Issue 2, 2002, Pages 132-134

  Tennant, Forest ^a   Hermann, Laura ^a  

^a Veract Intractable Pain Centers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CODEINE; CORTICOSTEROID; DEXTROPROPOXYPHENE; FENTANYL; FENTANYL CITRATE; HYDROCODONE; HYDROCORTISONE; LONG ACTING DRUG; METHADONE; MORPHINE; OPIATE; OXYCODONE;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOCRINE FUNCTION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; SEROLOGY;

EID: 0036341892     PISSN: 15262375     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4637.2002.02019.x     Document Type: Article

References (14)

1. Suffering: The contributions of persistent pain
2. Effect of pain on diurnal pattern of plasma corticoid levels
3. Intractable pain is a severe stress state associated with hypercortisolemia and reduced adrenal reserve
4. Biochemical changes associated with intractable pain
5. Chronic pain syndrome: What is it: And how can we help?
6. Induction of the intermediate pituitary by stress: Synthesis and release of a nonopioid form of beta-endorphin
7. Pain can kill
8. Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides
9. Opiate modulation of the pituitary-adrenal axis: Effects of stress and circadian rhythm
10. Adrenal steroids indirectly modulate morphine and betaendorphin effects
11. Blood-brain barrier: Endogenous modulation by adrenal-cortical function
12. Cosyntropin (ACTH alpha 1-24) stimulation test in depressed patients and healthy subjects
13. Abnormal adrenal gland metabolism in opioid addicts: Implications for clinical treatment
14. Effect of morphine and nalorphine on plasma hydrocortisone levels in man